Aug 2026· Small· pp.
e74965
· 0 citations· 188 references
Medicine
TL;DR
This review provides the first comprehensive focus on the combined application of NIR-mediated PTT/PDT with gas therapy (GT), chemodynamic therapy (CDT), immunotherapy, antibiotic adjuvants, and sonodynamic therapy (SDT), and highlights the current challenges and prospects for clinical translation.
Abstract
Bacterial infections, particularly those caused by multidrug-resistant pathogens and biofilm formation, have significantly undermined the efficacy of conventional antibiotics, highlighting the urgent need for novel antibacterial strategies. NIR-driven photothermal (PTT) and photodynamic therapies (PDT) have emerged as promising non-antibiotic approaches due to their noninvasive nature and precise spatiotemporal controllability. However, single-modality NIR treatments remain constrained by potential thermal damage to healthy tissues and reduced efficacy within the infection microenvironment. To address these limitations, researchers have developed NIR-mediated multimodal strategies that integrate complementary mechanisms for synergistic antimicrobial effects. Despite increasing studies, a systematic overview of NIR-based synergistic antibacterial strategies remains lacking. This review provides the first comprehensive focus on the combined application of NIR-mediated PTT/PDT with gas therapy (GT), chemodynamic therapy (CDT), immunotherapy, antibiotic adjuvants, and sonodynamic therapy (SDT). We summarize recent advances, discuss how these approaches overcome resistance, disrupt biofilm barriers, enhance antibacterial efficiency, and promote wound healing, and highlight the current challenges and prospects for clinical translation in this rapidly evolving field.
This work comprehensively summarize the natural prototypes, design principles, and recent material advances in bioinspired targeting for aPDT, and conducts a comparative analysis of these strategies in terms of mechanisms, advantages, limitations, biosafety, and optimization pathways.
Xin-Yu Yu, Jing-Zhu Qu, Kun-Hao Li et al.· Materials Horizons· 0 citations
Antimicrobial resistance has become a formidable global public health threat, with traditional antibiotic development lagging far behind the emergence of drug-resistant pathogens. Antimicrobial photodynamic therapy (aPDT) has emerged as a promising non-antibiotic alternative due to its low resistance propensity and spa...
Yi-Meng Wang, Jin-Hui Zhou, Xu-Zhe Lin et al.· Biomedical Engineering Commu...· 0 citations
This review comprehensively examines resistance mechanisms across major microbial pathogens and discusses the evolution of nanomedicine as an advanced platform for combating AMR, highlighting the synergistic interactions between nanomaterials and conventional antimicrobial agents that enhance therapeutic efficacy and r...
Vishal L. Handa, Benedict B. Vyas, Abhishek Padhi et al.· Frontiers in Chemistry· 0 citations
Bacterial infections, especially deep-seated tissue infections caused by drug-resistant bacteria and the formation of biofilms, have become a major challenge in modern medicine. Traditional antibiotic treatment faces problems such as decreased efficiency, side effects, and further induction of drug resistance. Therefor...
Zhen-Xing Yang, Cui-Hong Chen, Xiang-Mei Liu et al.· Small· 0 citations
Recent advances in nanotechnology-based strategies for combating AMR are summarized, highlighting the mechanisms of action, therapeutic applications, current research progress, and future translational prospects.
Pawan Swami, Priya D. Chouragade· Journal of Drug Delivery and...· 0 citations
Comparative studies suggest that combination approaches, including enzyme functionalized or stimuli responsive nanoparticles paired with antibiotics, may outperform single modality treatments by simultaneously disrupting the biofilm matrix and delivering active agents.
Husni Farah, Munthar Kadhim-Abosaoda, Hayjaa Mohaisen-Mousa et al.· Microfluidics and Nanofluidi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.